StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.08−0.02 (-0.95%)

Close on Nov 18, 2026Market cap $113.92MP/E –Yield –

Upstream Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Upstream Bio's price to sales ratio was 55.5× on Nov 11, 2026, against 357.7× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202655.5×−316.1
2025Sep 30, 2025371.6×+349.1
2024Dec 31, 202422.5×–

More Upstream Bio figures

See a number that looks wrong?